Compositions capable of reducing elevated blood urea concentration
US7576174B2 · kind B2 · utility
6Cited by
16References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2006 |
| Grant date | Aug 18, 2009 |
| Priority date | — |
| Expiry date | Nov 15, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes a method of reducing urea concentration in a subject's serum. Such a method comprises administering to the subject (e.g., a mammal such as a human) a composition comprising an oligopeptide (or oligopeptides) having activity in reducing urea concentration in the subject's serum as determined by a mouse renal reperfusion test, wherein the oligopeptide comprises the sequence AQG or MTRV (SEQ ID NO:1), AQGV (SEQ ID NO:2) or LAGV (SEQ ID NO:4).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.